Eczema-Society-of-Canada-Logo

ESC announces 2020 Research Grant Program recipients

Dr Jan Dutz 270x300 1Dr Touraj Khosravi 219x300 1ESC is pleased to announce that University of British Columbia researchers are the recipients of our 2020 Research Grant Program. We received applications from researchers from leading universities across Canada.

This years winners are:

  • Dr. Jan Dutz, MD, FRCPC, Professor and Head, Department of Dermatology and Skin Science, Senior Scientist, BC Children’s Hospital Research Institute, University of British Columbia
  • Dr. Touraj Khosravi, MD, 2nd year resident in the Department of Dermatology and Skin Science, University of British Columbia

Dr. Jan P. Dutz, MD, FRCPC and Dr. Touraj Khosravi, MD won the 2020 Grant for their project entitled The Role of IL-7 and IL-15 on Tissue Resident Memory T-Cells in the Recurrence of Dermatitis. This research could lead to breakthroughs for the understanding and potential treatment of eczema and atopic dermatitis.

Amanda Cresswell-Melville, ESC’s Executive Director says, “ESC is pleased with the impact ESC’s competitive Research Grant Program is having on eczema advancement in Canada. We are proud to have a thriving Research Grant Program that directly supports our mission of advancing eczema research in Canada. Dr. Dutz and Dr. Khosravi’s research has the potential to change our understanding of the disease.”

The focus of the Research Grant Program is to facilitate research that aims to improve care and quality of life for eczema sufferers. Specific areas of focus may include, but are not limited to, atopic dermatitis, hand eczema, and contact dermatitis.

Stay tuned as ESC will be announcing its call to applications for the 2021 Research Grant Program soon. Visit eczemahelp.ca for more information.

Related Articles

Global Title Goes Here

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc semper mi feugiat ultrices ibendum. Donec gravida, purus sit amet iaculis molestie, magna metus convallis justo, vel dignissim lacus lectus id turpis.

 

Subscribe and stay informed

Skip to content